Thomas King
Family · Jamestown, CANPI 1497005268
Payments from drug & device makers
Across 117 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$575
- Indivior Inc.$385
- Corcept Therapeutics$214
- Braeburn Inc.$174
- Biohaven Pharmaceuticals, Inc.$161
- Collegium Pharmaceutical, Inc.$134
- plus $564 from 14 others
What the payments were for
- Food & beverage$2,207100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUBLOCADE$109
How this compares
$2,207 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 84 | $64,849 |
| Nurtec OdtRimegepant Sulfate | 39 | $56,133 |
| SublocadeBuprenorphine | 19 | $38,538 |
| OxycontinOxycodone Hcl | 50 | $28,657 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 217 | $24,183 |
| BrixadiBuprenorphine | 13 | $22,620 |
| Nucynta ErTapentadol Hcl | 27 | $21,214 |
| Xtampza ErOxycodone Myristate | 22 | $17,724 |
| Buprenorphine | 63 | $17,545 |
| Fentanyl | 74 | $13,376 |
| Morphine Sulfate ErMorphine Sulfate | 232 | $10,746 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 397 | $9,285 |
| BelsomraSuvorexant | 22 | $8,798 |
| SavellaMilnacipran Hcl | 12 | $5,888 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 119 | $4,906 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Xtampza Er | $134 | $103,788133 claims |
| PfizerNurtec Odt | $47 | $56,13339 claims |
| Indivior Inc.Sublocade | $385 | $38,53819 claims |
| Braeburn Inc.Brixadi | $174 | $22,62013 claims |
| AbbVieSavella | $575 | $5,88812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.
Other family in Jamestown
- Gina Valente MooreJamestown$31K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.